BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16054788)

  • 1. Preparation and characterization of uniform nanosized cephradine by combination of reactive precipitation and liquid anti-solvent precipitation under high gravity environment.
    Zhong J; Shen Z; Yang Y; Chen J
    Int J Pharm; 2005 Sep; 301(1-2):286-93. PubMed ID: 16054788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micronization of gemfibrozil by reactive precipitation process.
    Huang QP; Wang JX; Chen GZ; Shen ZG; Chen JF; Yun J
    Int J Pharm; 2008 Aug; 360(1-2):58-64. PubMed ID: 18502064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanosized bicalutamide and its molecular structure in solvents.
    Le Y; Ji H; Chen JF; Shen Z; Yun J; Pu M
    Int J Pharm; 2009 Mar; 370(1-2):175-80. PubMed ID: 19101616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micronization of atorvastatin calcium by antisolvent precipitation process.
    Zhang HX; Wang JX; Zhang ZB; Le Y; Shen ZG; Chen JF
    Int J Pharm; 2009 Jun; 374(1-2):106-13. PubMed ID: 19446766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of ultrafine fenofibrate powder by solidification process from emulsion.
    Huang QP; Wang JX; Zhang ZB; Shen ZG; Chen JF; Yun J
    Int J Pharm; 2009 Feb; 368(1-2):160-4. PubMed ID: 19010406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
    Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ
    Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method.
    Li XS; Wang JX; Shen ZG; Zhang PY; Chen JF; Yun J
    Int J Pharm; 2007 Sep; 342(1-2):26-32. PubMed ID: 17566675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
    Jelvehgari M; Atapour F; Nokhodchi A
    Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of phenytoin nanoparticles using rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process.
    Thakur R; Gupta RB
    Int J Pharm; 2006 Feb; 308(1-2):190-9. PubMed ID: 16352406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of mesostructured barium sulfate with high surface area by dispersion method and its characterization.
    Nagaraja BM; Abimanyu H; Jung KD; Yoo KS
    J Colloid Interface Sci; 2007 Dec; 316(2):645-51. PubMed ID: 17897664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
    Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
    Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinol-encapsulated low molecular water-soluble chitosan nanoparticles.
    Kim DG; Jeong YI; Choi C; Roh SH; Kang SK; Jang MK; Nah JW
    Int J Pharm; 2006 Aug; 319(1-2):130-8. PubMed ID: 16713152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low density porous carrier drug adsorption and release study by response surface methodology using different solvents.
    Sher P; Ingavle G; Ponrathnam S; Pawar AP
    Int J Pharm; 2007 Feb; 331(1):72-83. PubMed ID: 17030470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement.
    Tao T; Zhao Y; Wu J; Zhou B
    Int J Pharm; 2009 Feb; 367(1-2):109-14. PubMed ID: 18930795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of stabilized itraconazole nanodispersions by using high-gravity technique.
    Zhang ZL; Le Y; Wang JX; Zhao H; Chen JF
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1512-20. PubMed ID: 22435399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitation.
    Zu Y; Sun W; Zhao X; Wang W; Li Y; Ge Y; Liu Y; Wang K
    Eur J Pharm Sci; 2014 Mar; 53():109-17. PubMed ID: 24345795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants.
    Zhang JY; Shen ZG; Zhong J; Hu TT; Chen JF; Ma ZQ; Yun J
    Int J Pharm; 2006 Oct; 323(1-2):153-60. PubMed ID: 16828244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of melt granulation and ultrasonic spray congealing as techniques to enhance the dissolution of praziquantel.
    Passerini N; Albertini B; Perissutti B; Rodriguez L
    Int J Pharm; 2006 Aug; 318(1-2):92-102. PubMed ID: 16697539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies.
    Trapani A; Laquintana V; Denora N; Lopedota A; Cutrignelli A; Franco M; Trapani G; Liso G
    Eur J Pharm Sci; 2007 Jan; 30(1):64-74. PubMed ID: 17118631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.